Additional file 2: Table S2. of IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
Yuhang Zhou, Wei Kang(Chinese University of Hong Kong), Alfred S.L. Cheng(Chinese University of Hong Kong), William Ka Kei Wu(Quantitative BioSciences), Ho Lam Siu, Chi Kuen Wong(Hong Kong Baptist University), Tingting Huang(Dartmouth College), Bin Zhang(King Abdullah University of Science and Technology), Jun Yu(Yueyang Second People's Hospital), Feng Wu(Shanghai Institute of Technical Physics), Yujuan Dong(Chinese University of Hong Kong), Ka‐Fai To(Chinese University of Hong Kong)
Cited by 0
Related Papers
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
|Journal of Clinical Oncology|2018|473
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
|Molecular Cancer|2017|429
MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
|Gastroenterology|2008|424